Australian Statistics on Medicines 2010

Table 1 - Cardiovascular System

C01 - CARDIAC THERAPY

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
CARDIAC GLYCOSIDES
DIGITALIS GLYCOSIDES
C01AA05 DIGOXIN
P 1322N Tablet 250ug 0.25 MG 132,959 1,438,749
P 2605D Tablet 62.5ug 0.25 MG 286,828 3,013,389
P 3164M Oral solution for children 50ug per mL, 100mL 0.25 MG 499 13,375
ANTIARRHYTHMICS CLASS I AND III
ANTIARRHYTHMICS CLASS IA
C01BA03 DISOPYRAMIDE
P 2923W Capsule 100mg 0.40 GM 4,688 130,543
P 2924X Capsule 150mg 0.40 GM 2,964 122,300
ANTIARRHYTHMICS CLASS IB
C01BB01 LIGNOCAINE HYDROCHLORIDE
P 2875H Injection 100mg in 5mL 3.00 GM 1,580 65,224
P 2876J Infusion 500mg in 5mL 3.00 GM 244 8,829
P 3474W Injection 100mg in 5mL 3.00 GM 8,374 311,648
C01BB02 MEXILETINE HYDROCHLORIDE
P 1682M Capsule 50mg 0.80 GM 3,041 108,930
P 1683N Capsule 200mg 0.80 GM 3,019 193,147
ANTIARRHYTHMICS CLASS IC
p>C01BC04   FLECAINIDE ACETATE
P 1088G Tablet 50mg 60 0.20 GM 82,875 3,277,969
P 1090J Tablet 100mg 0.20 GM 119,487 5,646,619
ANTIARRHYTHMICS CLASS III
C01BD01 AMIODARONE HYDROCHLORIDE
P 2343H Tablet 200mg 0.20 GM 259,766 5,662,171
P 2344J Tablet 100mg 0.20 GM 119,024 1,794,493
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
ADRENERGIC AGENTS
C01CA24 ADRENALINE
P 1016L Injection 1mg in 1mL (1 in 1,000) 0.50 MG 3,001 65,358
P 3408J I.M. injection 150ug in 0.3mL single dose auto-injector 0.50 MG 176 34,975
P 3409K I.M. injection 300ug in 0.3mL single dose auto-injector 0.50 MG 293 55,005
P 3451P Injection 1mg in 1mL (1 in 1,000) 0.50 MG 27,310 555,216
P 8697R I.M. injection 150mg in 0.3mL syringe 0.50 MG 23,256 4,519,560
P 8698T I.M. injection 300mg in 0.3mL syringe 0.50 MG 50,477 7,928,575
VASODILATORS USED IN CARDIAC DISEASES
ORGANIC NITRATES
C01DA02 GLYCERYL TRINITRATE
P 1459T Tablets 600ug 100 2.50 MG 71,986 897,917
P 1515R Td pad releasing approx. 5mg per 24 hours 5.00 MG 191,127 5,331,611
P 1516T Td pad releasing approx. 10mg per 24 hours 5.00 MG 100,785 3,493,894
P 3475X Buccal/sublingual spray (pump pack) 400ug per dose 2.50 MG 20,034 403,302
P 8010N Td patch releasing approx. 5mg per 24 hours 5.00 MG 95,532 2,669,618

C01 - CARDIAC THERAPY

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
CARDIAC THERAPY
VASODILATORS USED IN CARDIAC DISEASES
P 8011P Td patch releasing approx. 10mg per 24 hours 5.00 MG 48,420 1,680,270
P 8026K Td patch releasing approx. 1mg per 24 hours 5.00 MG 19,066 661,572
P 8027L Td patch releasing approx. 5mg per 24 hours 5.00 MG 7,661 214,493
P 8028M Td patch releasing approx. 10mg per 24 hours 5.00 MG 5,567 193,271
P 8119H Td patch releasing approx. 15mg per 24 hours 5.00 MG 3,681 129,116
P 8171C Buccal/sublingual spray (pump pack) 400ug per dose 2.50 MG 306,803 6,134,174
C01DA08 ISOSORBIDE DINITRATE
P 2587E Tablet 10mg 60.00 MG 13,997 189,172
P 2588F Sublingual tablet 5mg 20.00 MG 6,539 93,891
C01DA14 ISOSORBIDE MONONITRATE
P 1558B Tablets sustained release 60mg 30 40.00 MG 701,708 9,093,970
P 8273K Tablets sustained release 120mg 30 40.00 MG 262,318 5,718,960
OTHER VASODILATORS USED IN CARDIAC DISEASES
C01DX16 NICORANDIL
P 8228C Tablet 10mg 40.00 MG 165,948 4,032,309
P 8229D Tablet 20mg 40.00 MG 77,961 2,446,928
OTHER CARDIAC PREPARATIONS
OTHER CARDIAC PREPARATIONS
C01EB17 IVABRADINE
A 19957 Tablets 5mg 56 10.00 MG 10,453 —
A 19958 Tablets 7.5mg 56 10.00 MG 3,008 —

C02 - ANTIHYPERTENSIVES

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
ANTIHYPERTENSIVES
ANTIADRENERGIC AGENTS CENTRALLY ACTING
METHYLDOPA
C02AB01 METHYLDOPA
P 1629R Tablet 250mg 1.00 GM 157,296 2,244,163
IMIDAZOLINE RECEPTOR AGONISTS
C02AC01 CLONIDINE
P 3141H Tablet 150ug 0.45 MG 31,429 1,202,942
P 3145M Tablet 100ug 0.45 MG 108,812 3,142,865
C02AC05 MOXONIDINE
P 9019Q Tablet 200mg 30 0.30 MG 190,500 3,903,792
P 9020R Tablet 400mg 30 0.30 MG 147,555 4,326,338
ANTIADRENERGIC AGENTS PERIPHERALLY ACTING
ALPHA - ADRENOCEPTOR BLOCKING AGENTS
C02CA01 PRAZOSIN HYDROCHLORIDE
P 1478T Tablet 5mg (base) 5.00 MG 123,136 2,598,908
P 1479W Tablet 1mg (base) 5.00 MG 324,436 4,064,751
P 1480X Tablet 2mg (base) 5.00 MG 188,995 2,825,698
ARTERIOLAR SMOOTH MUSCLE AGENTS ACTING ON
HYDRAZINOPHTHALAZINE DERIVATIVES
C02DB02 HYDRALAZINE HYDROCHLORIDE
P 1639G Tablet 50mg 0.10 GM 28,295 484,530
P 1640H Tablet 25mg 0.10 GM 33,692 511,939
PYRIMIDINE DERIVATIVES
C02DC01 MINOXIDIL
P 2313R Tablet 10mg 20.00 MG 5,505 308,876
OTHER ANTIHYPERTENSIVES
OTHER ANTHIYPERTENSIVES
C02KX02 AMBRISENTAN
P 9648T Tablet 5mg 30 7.50 MG 386 1,573,294
P 9649W Tablet 10mg 30 7.50 MG 286 1,166,497
C02KX01 BOSENTAN
P 6429J Tablet 62.5mg (base) 60 0.25 MG 432 1,674,523
P 6430K Tablet 125mg (base) 60 0.25 MG 7,640 31,161,171
C02KX03 SITAXENTAN
P 9622K Tablet 100mg 30 0.10 GM 1,288 3,595,952

C03 - DIURETICS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
DIURETICS
LOW-CEILING DIURETICS THIAZIDES
THIAZIDES PLAIN
C03AA03 HYDROCHLOROTHIAZIDE
P 1484D Tablet 25mg 25.00 MG 92,985 1,960,695
LOW-CEILING DIURETICS EXCL. THIAZIDES
SULFONAMIDES PLAIN
C03BA04 CHLORTHALIDONE
P 1585K Tablet 25mg 25.00 MG 30,159 409,346
C03BA11 INDAPAMIDE
P 2436F Tablet 2.5mg 90 2.50 MG 162,440 2,833,871
P 8532C Tablet 1.5mg (sustained release) 90 2.50 MG 380,058 7,325,279
HIGH-CEILING DIURETICS
SULFONAMIDES PLAIN
C03CA02 BUMETANIDE
A 17855 Tablet 1mg 1.00 MG 6,108 —
C03CA01 FRUSEMIDE
P 2411X Oral solution 10mg per mL 30mL 40.00 MG 3,102 56,515
P 2412Y Tablet 40mg 40.00 MG 1,232,088 10,838,955
P 2413B Injection 20mg in 2mL 40.00 MG 6,920 80,737
P 2414C Tablet 20mg 40.00 MG 292,538 2,625,188
P 2415D Tablet 500mg 40.00 MG 14,460 263,514
P 3466K Injection 20mg in 2mL 40.00 MG 9,158 95,971
ARYLOXYACETIC ACID DERIVATIVES
C03CC01 ETHACRYNIC ACID
P 8748K Tablet 25mg 50.00 MG 2,398 445,083
POTASSIUM-SPARING AGENTS
ALDOSTERONE ANTAGONISTS
C03DA04 EPLERENONE
P 8879H Tablet 25mg 30 50.00 MG 10,958 1,257,157
P 8880J Tablet 50mg 30 50.00 MG 2,094 245,931
C03DA01 SPIRONOLACTONE
P 2339D Tablet 25mg 75.00 MG 322,654 3,989,664
P 2340E Tablet 100mg 75.00 MG 60,221 1,811,907
OTHER POTASSIUM-SPARING AGENTS
C03DB01 AMILORIDE HYDROCHLORIDE
P 3109P Tablet 5mg 10.00 MG 22,634 249,433
DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
LOW-CEILING DIURETICS AND POTASSIUM-SPARING AGENTS
C03EA01 HYDROCHLOROTHIAZIDE with AMILORIDE HYDROCHLORIDE
P 1486F Tablet 50mg-5mg — — 134,091 1,850,634
C03EA01 HYDROCHLOROTHIAZIDE with TRIAMTERENE
P 1280J Tablet 25mg-50mg 100 — — 30,899 397,738

C04 - PERIPHERAL VASODILATORS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
PERIPHERAL VASODILATORS
PERIPHERAL VASODILATORS
PURINE DERIVATIVES
C04AD03 OXPENTIFYLLINE
A 17632 Tablet 400mg 50 1.00 GM 732 —
OTHER PERIPHERAL VASODILATORS
C04AX02 PHENOXYBENZAMINE HYDROCHLORIDE
P 1862B Capsule 10mg 30 30.00 MG 215 14,296
P 9286R Capsule 10mg 100 30.00 MG 1,615 2,060,783

C05 - VASOPROTECTIVES

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
VASOPROTECTIVES
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
CORTICOSTEROIDS
C05AA01 HYDROCORTISONE with CINCHOCAINE HYDROCHLORIDE
P 4036K Ointment 5mg-5mg per g (0.5%-0.5%) 30g — — 6,868 149,011
C05AA01 HYDROCORTISONE, CINCHOCAINE HYDROCHLORIDE
A 14345 Ointment 5mg-5mg-10mg per g (0.5%-0.5%-1%) — — 3,755 —
P 4038M Suppositories 5mg-5mg 12 — — 7,356 156,032
C05AA01 HYDROCORTISONE, LIGNOCAINE BASE, ALUMINIUM SUBACETATE and ZINC OXIDE
A 14653 Ointment 2.5mg-50mg-35mg-180mg per g — — 1,660 —
C05AA04 PREDNISOLONE HEXANOATE, CINCHOCAINE HYDROCHLORIDE and CLEMIZOLE UNDECYLENATE
A 14656 Ointment 1.9mg-5mg-10mg per g (0.16-0.5%-1%) — — 13,387 —
A 14657 Ointment 1.9mg-5mg-10mg per g (0.195-0.5%-1%) — — 14,218 —
A 14658 Suppositories 1.3mg-1mg-5mg 12 — — 8,901 —
LOCAL ANESTHETICS
C05AD03 ADRENALINE EPHEDRINE BENZOCAINE ZINC OXIDE
A 13134 Ointment 50g 1 — — 2,241 —
MUSCLE RELAXANTS
C05AE01 GLYCERYL TRINITRATE
A 16349 Ointment 0.2% 30g 1 — — 1,575 —
A 20786 Ointment 0.2% 15g 1 — — 253 —
OTHER AGENTS FOR TREATMENT HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05AX04 ZINC OXIDE
P 4039N Compound ointment 50g — — 2,424 34,967
P 4040P Compound suppositories, 12 — — 1,535 21,300
ANTIVARICOSE THERAPY
HEPARINS OR HEPARINOIDS FOR TOPICAL USE
C05BA01 HEPARINOID
A 12829 Cream 0.3%40g 1 — — 285 —
A 13774 Cream 0.3% 20g 1 — — 807 —
CAPILLARY STABILIZING AGENTS
BIOFLAVONOIDS
C05CA02 HYDROXYETHYLRUTOSIDES
A 16101 Capsule 250mg 100 — — 196 —

C07 - BETA BLOCKING AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
BETA BLOCKING AGENTS
BETA BLOCKING AGENTS PLAIN
BETA BLOCKING AGENTS PLAIN NON-SELECTIVE
C07AA02 OXPRENOLOL HYDROCHLORIDE
P 2942W Tablet 20mg 0.16 GM 1,495 14,944
P 2961W Tablet 40mg 0.16 GM 9,715 116,971
C07AA03 PINDOLOL
P 3062E Tablet 5mg 15.00 MG 19,546 224,792
P 3065H Tablet 15mg 15.00 MG 18,548 258,302
C07AA05 PROPRANOLOL HYDROCHLORIDE
P 2565B Tablet 10mg 0.16 GM 150,143 1,533,584
P 2566C Tablet 40mg 0.16 GM 306,362 3,248,736
P 2899N Tablet 160mg 0.16 GM 27,428 304,408
C07AA07 SOTALOL HYDROCHLORIDE
P 2043M Tablet 160mg 0.16 GM 102,325 2,741,733
P 8398B Tablet 80mg 60 0.16 GM 371,629 5,902,847
BETA BLOCKING AGENTS PLAIN SELECTIVE
C07AB03 ATENOLOL
P 1081X Tablet 50mg 0.08 GM 3,989,016 42,644,232
A 21266 Tablet 50mg 30 0.08 GM 234 —
C07AB07 BISOPROLOL
P 8604W Tablet 2.5mg 10.00 MG 203,461 10,372,590
P 8605X Tablet 5mg 10.00 MG 191,063 11,812,109
P 8606Y Tablet 10mg 10.00 MG 159,425 11,688,592
C07AB02 METOPROLOL SUCCINATE
P 8732N Tablet 23.75mg (controlled release) 15 150.00 MG 9,742 316,036
P 8733P Tablet 47.5mg (controlled release) 30 150.00 MG 38,863 2,901,711
P 8734Q Tablet 95mg (controlled release) 30 150.00 MG 38,423 3,516,685
P 8735R Tablet 190mg (controlled release) 30 150.00 MG 29,129 3,212,038
C07AB02 METOPROLOL TARTRATE
P 1324Q Tablet 50mg 150.00 MG 1,311,952 14,142,912
P 1325R Tablet 100mg 150.00 MG 446,511 5,403,151
C07AB12 NEBIVOLOL
P 9310B Tablet 1.25mg (as hydrochloride), 28 5.00 MG 1,524 45,278
P 9311C Tablet 5mg (as hydrochloride) 28 5.00 MG 3,286 202,635
P 9312D Tablet 10mg (as hydrochloride) 28 5.00 MG 1,357 91,825
P 9316H Tablet 1.25mg (as hydrochloride) 28 5.00 MG 1,068 43,674
ALPHA- AND BETA- ADRENOCEPTOR BLOCKING AGENTS
C07AG02 CARVEDILOL
P 8255L Tablet 3.125mg 30 37.50 MG 31,581 695,415
P 8256M Tablet 6.25mg 37.50 MG 123,097 6,452,233
P 8257N Tablet 12.5mg 37.50 MG 149,378 9,443,371
P 8258P Tablet 25mg 37.50 MG 267,394 21,279,528
C07AG01 LABETALOL HYDROCHLORIDE
P 1566K Tablet 100mg 0.60 GM 19,619 305,061

C07 - BETA BLOCKING AGENTS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
BETA BLOCKING AGENTS
BETA BLOCKING AGENTS PLAIN
P 1567L Tablet 200mg 0.60 GM 21,000 476,884

C08 - CALCIUM CHANNEL BLOCKERS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
CALCIUM CHANNEL BLOCKERS
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS
DIHYDROPYRIDINE DERIVATIVES
C08CA01 AMLODIPINE
P 1343Q Tablet 5mg (base) maleate salt 30 5.00 MG 278,933 4,648,928
P 1345T Tablet 10mg (base) maleate salt 30 5.00 MG 213,012 5,192,501
P 2751T Tablet 5mg (base) besylate salt 3 0 5.00 MG 1,387,227 23,296,695
P 2752W Tablet 10mg (base) besylate salt 30 5.00 MG 1,130,870 27,759,353
C08CA02 FELODIPINE
P 2361G Tablet 2.5mg (extended release) 5.00 MG 192,394 2,560,347
P 2366M Tablet 5mg (extended release) 5.00 MG 461,259 7,434,850
P 2367N Tablet 10mg (extended release) 5.00 MG 559,939 13,933,248
C08CA13 LERCANIPIDINE
P 8534E Tablet 10mg 30 10.00 MG 1,102,943 21,455,024
P 8679T Tablet 20mg 30 10.00 MG 912,851 25,555,152
P 8939L Tablet 10mg 30 10.00 MG 66,790 1,725,225
P 8940M Tablet 20mg 30 10.00 MG 83,506 2,902,181
C08CA05 NIFEDIPINE
P 1694E Tablet 10mg 60 30.00 MG 35,164 560,927
P 1695F Tablet 20mg 60 30.00 MG 32,604 604,869
P 1906H Tablet 30mg (controlled release) 30 30.00 MG 330,075 6,373,543
P 1907J Tablet 60mg (controlled release) 30 30.00 MG 315,002 7,325,032
P 8610E Tablet 20mg (controlled release) 30 30.00 MG 122,823 2,264,191
P 8938K Tablet 20mg (controlled release) 30 30.00 MG 5,670 134,292
SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS
PHENYLALKYLAMINE DERIVATIVES
C08DA01 VERAPAMIL HYDROCHLORIDE
P 1241H Tablet 240mg (sustained release) 0.24 GM 580,712 9,696,291
P 1248Q Tablet 40mg 0.24 GM 32,792 377,120
P 1250T Tablet 80mg 0.24 GM 30,765 473,847
P 1253Y Tablet 160mg 0.24 GM 12,980 242,643
P 1254B Tablet 120mg 0.24 GM 6,397 124,548
P 2206D Capsule 160mg (sustained release) 0.24 GM 56,639 727,306
P 2207E Capsule 240mg (sustained release) 0.24 GM 102,517 1,705,728
P 2208F Capsule 180mg (sustained release) 0.24 GM 219,683 3,109,265
P 3494X Injection 5mg in 2mL 0.24 GM 3,617 44,761
BENZOTHIAZEPINE DERIVATIVES
C08DB01 DILTIAZEM HYDROCHLORIDE
P 1312C Capsule 180mg controlled delivery 0.24 GM 481,000 8,328,539
P 1313D Capsule 240mg controlled delivery 0.24 GM 463,978 9,798,937
P 1335G Tablet 60mg 0.24 GM 53,123 865,472
P 8480H Capsule 360mg controlled delivery 30 0.24 GM 303,987 7,786,081
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
OTHER NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
C08EX02 PERHEXILINE MALEATE

C08 - CALCIUM CHANNEL BLOCKERS

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
CALCIUM CHANNEL BLOCKERS
NON-SELECTIVE CALCIUM CHANNEL BLOCKERS
P 1822X Tablet 100mg 0.20 GM 30,561 1,917,786

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS, PLAIN
CONVERTING ENZYME BLOCKERS
C09AA01 CAPTOPRIL
P 1147J Tablet 12.5mg 50.00 MG 5,580 92,604
P 1148K Tablet 25mg 50.00 MG 19,536 416,170
P 1149L Tablet 50mg 50.00 MG 31,770 1,154,787
P 8760C Oral solution 5mg per mL 95mL 50.00 MG 1,036 126,248
C09AA02 ENALAPRIL MALEATE
P 1368B Tablet 10mg 10.00 MG 157,278 2,847,230
P 1369C Tablet 20mg 10.00 MG 309,194 7,323,042
P 1370D Tablet 5mg 10.00 MG 71,211 951,339
C09AA09 FOSINOPRIL
P 1182F Tablet 10mg 30 15.00 MG 115,062 1,818,439
P 1183G Tablet 20mg 15.00 MG 217,661 4,803,187
C09AA03 LISINOPRIL
P 2456G Tablet 5mg 30 10.00 MG 95,704 1,361,486
P 2457H Tablet 10mg 30 10.00 MG 186,499 3,394,932
P 2458J Tablet 20mg 30 10.00 MG 344,926 7,801,925
C09AA04 PERINDOPRIL
P 3050M Tablet 2mg (erbumine) 30 4.00 MG 357,781 4,543,254
P 3051N Tablet 4mg (erbumine) 30 4.00 MG 647,918 11,734,742
P 8704D Tablet 8mg (erbumine) 30 4.00 MG 579,745 14,091,947
P 9006B Tablet 2.5mg (arginine) 30 4.00 MG 745,642 9,421,151
P 9007C Tablet 5mg (arginine) 30 4.00 MG 1,629,001 29,631,188
P 9008D Tablet 10mg (arginine) 30 4.00 MG 1,586,693 38,728,631
C09AA06 QUINAPRIL
P 1968N Tablet 5mg (as hydrochloride) 30 15.00 MG 35,534 498,717
P 1969P Tablet 10mg (as hydrochloride) 30 15.00 MG 96,682 1,681,182
P 1970Q Tablet 20mg (as hydrochloride) 30 15.00 MG 207,234 4,437,206
C09AA05 RAMIPRIL
P 1316G Tablet 10mg 30 2.50 MG 166,191 3,949,718
P 1944H Capsule 1.25mg 28 2.50 MG 157,272 1,824,795
P 1945J Capsule 2.5mg 28 2.50 MG 526,240 7,359,887
P 1946K Capsule 5.0mg 28 2.50 MG 1,006,771 16,304,367
P 8470T Capsule 10mg 30 2.50 MG 1,545,064 36,072,167
P 8668F Pack 7 Tabs 2.5mg 21 tabs 5mg and 10 caps 10mg 2.50 MG 1,259 27,764
P 9120B Capsule 1.25mg 30 2.50 MG 5,683 65,844
P 9121C Capsule 2.5mg 30 2.50 MG 20,861 286,144
P 9122D Capsule 5.0mg 30 2.50 MG 30,252 481,855
C09AA10 TRANDOLAPRIL
P 2791X Capsule 500ug 2.00 MG 22,460 213,598
P 2792Y Capsule 1mg 2.00 MG 70,052 1,002,060
P 2793B Capsule 2mg 2.00 MG 159,122 2,596,394
P 8758Y Capsule 4mg 28 2.00 MG 156,096 3,808,999

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
ACE INHIBITORS, COMBINATIONS
ACE INHIBITORS, COMBINATIONS
ANGIOTENSIN-CONVERTING ENZYME BLOCKERS AND DIURETICS
C09BA02 ENALAPRIL with HYDROCHLOROTHIAZIDE
P 8477E Tablet 20mg-6mg — — 138,137 3,995,318
C09BA09 FOSINOPRIL with HYDROCHLOROTHIAZIDE
P 8400D Tablet 10mg-12.5mg — — 61,163 1,337,188
P 8401E Tablet 20mg-12.5mg — — 379,461 11,108,634
C09BA04 PERINDOPRIL with INDAPAMIDE
P 2190G Tablet 2.5mg (arginine)-0.625mg 30 — — 48,111 790,202
P 2845R Tablet 5mg (arginine)-1.25mg 30 — — 1,335,768 39,579,138
P 8449Q Tablet 4mg (erbumine)-1.25mg 30 — — 425,056 12,312,778
C09BA06 QUINAPRIL with HYDROCHLOROTHIAZIDE
P 8589C Tablet 10mg(base) / 12.5mg 30 — — 16,479 322,027
P 8590D Tablet 20mg(base) / 12.5mg 30 — — 92,734 2,052,762
ACE INHIBITORS AND CALCIUM CHANNEL BLOCKERS
C09BB02 ENALAPRIL and LERCANIDIPINE
P 9144G Tablet 10mg-10mg 30 — — 39,177 1,227,704
P 9145H Tablet 10mg-20mg 30 — — 81,299 2,744,295
C09BB04 PERINDOPRIL and AMLODIPINE
P 9346X Tablet 5mg-5mg 30 — — 26,336 746,299
P 9347Y Tablet 5mg-10mg 30 — — 8,171 294,540
P 9348B Tablet 10mg-5mg 30 — — 43,572 1,504,620
P 9349C Tablet 10mg-10mg 30 — — 35,088 1,475,784
C09BB05 RAMIPRIL and FELODIPINE
P 2626F Tablet 2.5mg-2.5mg 30 — — 9,306 195,885
P 2629J Tablet 5mg-5mg 30 — — 75,050 2,081,743
C09BB10 TRANDOLAPRIL and VERAPAMIL
P 2857J Tablet 4mg-240mg (sustained release) 28 — — 61,894 2,060,676
P 9387C Tablet 2mg-180mg (sustained release) 28 — — 10,805 248,060
ANGIOTENSIN II ANTAGONISTS
ANGIOTENSIN II ANTAGONISTS PLAIN
C09CA06 CANDESARTAN
P 8295N Tablet 4mg 30 8.00 MG 295,938 5,824,516
P 8296P Tablet 8mg 30 8.00 MG 867,849 20,234,251
P 8297Q Tablet 16mg 30 8.00 MG 1,064,810 31,423,236
P 8889W Tablet 32mg 30 8.00 MG 553,249 25,859,326
C09CA02 EPROSARTAN
P 8397Y Tablet 400mg (base) 56 0.60 GM 23,227 674,369
P 8447N Tablet 600mg (base) 28 0.60 GM 77,018 2,382,084
P 8951D Tablet 400mg (base) 56 0.60 GM 621 19,350
C09CA04 IRBESARTAN
P 8246B Tablet 75mg 150.00 MG 573,668 12,149,834
P 8247C Tablet 150mg 150.00 MG 1,699,398 42,938,847

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
ANGIOTENSIN II ANTAGONISTS
P 8248D Tablet 300mg 150.00 MG 1,931,857 58,799,343
C09CA01 LOSARTAN
A 16073 Tablet 50mg 30 0.05 GM 2,019 —
C09CA08 OLMESARTAN MEDOXOMIL
P 2147B Tablet 20mg 30 20.00 MG 239,264 6,037,780
P 2148C Tablet 40mg 30 20.00 MG 201,322 6,270,209
C09CA07 TELMISARTAN
P 8355R Tablet 40mg 40.00 MG 1,213,557 26,343,751
P 8356T Tablet 80mg 40.00 MG 1,207,920 35,171,829
C09CA03 VALSARTAN
P 9368C Tablet 40mg 28 80.00 MG 3,324 53,687
P 9369D Tablet 80mg 28 80.00 MG 43,162 870,267
P 9370E Tablet 160mg 28 80.00 MG 25,240 608,539
P 9371F Tablet 320mg 28 80.00 MG 7,219 206,665
ANGIOTENSIN II ANTAGONISTS COMBINATIONS
ANGIOTENSIN II ANTAGONISTS AND DIURETICS
C09DA06 CANDESARTAN with HYDROCHLOROTHIAZIDE
P 8504N Tablet 16mg-12.5mg 30 — — 1,053,194 33,487,645
P 9314F Tablet 32mg-12.5mg 30 — — 78,166 3,790,042
P 9315G Tablet 32mg-25mg 30 — — 34,115 1,720,543
C09DA02 EPROSARTAN with HYDROCHLOROTHIAZIDE
P 8624X Tablet 600mg (base) -12.5mg 28 — — 90,259 2,931,130
C09DA04 IRBESARTAN with HYDROCHLOROTHIAZIDE
P 2136K Tablet 300mg-25mg 30 — — 447,763 15,524,459
P 8404H Tablet 150mg-12.5mg 30 — — 698,856 19,112,038
P 8405J Tablet 300mg-12.5mg 30 — — 2,281,690 74,100,927
C09DA08 OLMESARTAN with HYDROCHLOROTHIAZIDE
P 2161R Tablet 20mg 12.5mg 30 — — 62,820 1,715,894
P 2166B Tablet 40mg 12.5mg 30 — — 140,175 4,545,893
P 2170F Tablet 40mg 25mg 30 — — 122,831 4,258,612
C09DA07 TELMISARTAN with HYDROCHLOROTHIAZIDE
P 8622T Tablet 40mg-12.5mg 28 — — 262,526 6,222,511
P 8623W Tablet 80mg-12.5mg 28 — — 1,009,664 31,276,557
P 9381R Tablet 80mg-25mg 28 — — 146,857 4,855,527
C09DA03 VALSARTAN with HYDROCHLOROTHIAZIDE
P 9372G Tablet 80mg-12.5mg 28 — — 5,659 125,149
P 9373H Tablet 160mg-12.5mg 28 — — 9,796 254,988
P 9374J Tablet 160mg-25mg 28 — — 5,275 147,971
P 9481B Tablet 320mg-12.5mg 28 — — 3,133 96,387
P 9482C Tablet 320mg-25mg 28 — — 2,461 80,541
ANGIOTENSIN II ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS
C09DB01 AMLODIPINE and VALSARTAN
P 9375K Tablet 5mg as (besylate)-80mg 28 — — 47,571 1,415,708

C09 - AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
AGENTS ACTING ON RENIN-ANGIOTENSIN SYSTEM
ANGIOTENSIN II ANTAGONISTS COMBINATIONS
P 9376L Tablet 5mg as (besylate)-160mg 28 — — 93,828 3,148,113
P 9377M Tablet 10mg as (besylate)-160mg 28 — — 107,120 4,356,017
C09DB02 OLMESARTAN with AMLODIPINE
P 5292M Tablet containing olmesartan medoxomil 20mg with amlodipine 5mg (as besylate) — — 387 13,639
P 5293N Tablet containing olmesartan medoxomil 40mg with amlodipine 5mg (as besylate) — — 692 28,099
P 5294P Tablet containing olmesartan medoxomil 40mg with amlodipine 10mg (as besylate) — — 588 27,754
ANGIOTENSIN II ANTAGONISTS OTHER COMBINATIONS
C09DX01 AMLODIPINE with VALSARTAN and HYDROCHLOROTHIAZIDE
P 5285E Tablet 5mg (as besylate)-160mg-12.5mg — — 738 26,236
P 5286F Tablet 5mg (as besylate)-160mg-25mg — — 219 8,232
P 5287G Tablet 10mg (as besylate)-160mg-12.5mg — — 779 33,065
P 5288H Tablet 10mg (as besylate)-160mg-25mg — — 300 13,264
P 5289J Tablet 10mg (as besylate)-320mg-25mg — — 398 19,187

C10 - LIPID MODIFYING AGENTS PLAIN

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS PLAIN
LIPID MODIFYING AGENTS PLAIN
HMG REDUCTASE INHIBITORS
C10AA05 ATORVASTATIN
P 8213G Tablet 10mg (as calcium) 30 20.00 MG 1,672,552 71,287,889
P 8214H Tablet 20mg (as calcium) 30 20.00 MG 3,685,770 213,541,726
P 8215J Tablet 40mg (as calcium) 30 20.00 MG 3,994,901 315,634,981
P 8521L Tablet 80mg (as calcium) 30 20.00 MG 1,431,636 157,631,739
P 9230T Tablet 10mg (as calcium) 30 20.00 MG 43,825 1,867,293
P 9231W Tablet 20mg (as calcium) 30 20.00 MG 99,500 5,763,631
P 9232X Tablet 40mg (as calcium) 30 20.00 MG 121,521 9,598,079
P 9233Y Tablet 80mg (as calcium) 30 20.00 MG 49,605 5,459,707
C10AA04 FLUVASTATIN
P 2863Q Tablet 80mg (as sodium) (prolonged release) 28 60.00 MG 21,974 1,021,333
P 8023G Capsule 20mg (as sodium) 28 60.00 MG 25,341 661,636
P 8024H Capsule 40mg (as sodium) 28 60.00 MG 36,676 1,152,902
P 9234B Capsule 20mg (as sodium) 28 60.00 MG 659 17,179
P 9235C Capsule 40mg (as sodium) 28 60.00 MG 1,008 34,093
P 9236D Capsule 80mg (as sodium) 28 60.00 MG 992 46,078
C10AA03 PRAVASTATIN
A 21311 Tablet 10mg 30 30.00 MG 228 —
P 2833D Tablet 10mg 30 30.00 MG 80,856 1,740,269
P 2834E Tablet 20mg 30 30.00 MG 315,290 9,618,546
P 8197K Tablet 40mg 30 30.00 MG 659,955 28,728,181
P 8829Q Tablet 80mg 30 30.00 MG 134,982 8,296,308
P 9237E Tablet 10mg 30 30.00 MG 2,509 53,719
P 9238F Tablet 20mg 30 30.00 MG 10,703 326,201
P 9239G Tablet 40mg 30 30.00 MG 19,025 827,638
P 9240H Tablet 80mg 30 30.00 MG 6,663 409,613
C10AA07 ROSUVASTATIN
P 3402C Tablet 5mg (as calcium) 30 10.00 MG 5,393 245,898
P 3403D Tablet 10mg (as calcium) 30 10.00 MG 9,757 607,468
P 3404E Tablet 20mg (as calcium) 30 10.00 MG 5,302 455,368
P 3405F Tablet 40mg (as calcium) 30 10.00 MG 2,629 315,214
P 9042X Tablet 5mg (as calcium) 30 10.00 MG 885,445 41,460,046
P 9043Y Tablet 10mg (as calcium) 30 10.00 MG 2,668,036 170,882,212
P 9044B Tablet 20mg (as calcium) 30 10.00 MG 1,264,015 111,621,059
P 9045C Tablet 40mg (as calcium) 30 10.00 MG 581,923 71,686,089
C10AA01 SIMVASTATIN
P 2011W Tablet 10mg 30.00 MG 472,339 11,805,259
P 2012X Tablet 20mg 30.00 MG 1,502,294 49,799,827
P 2013Y Tablet 5mg 30.00 MG 24,075 477,587
P 8173E Tablet 40mg 30.00 MG 2,047,450 90,898,071
P 8313M Tablet 80mg 30.00 MG 559,559 33,215,158
P 9241J Tablet 5mg 30 30.00 MG 814 16,187

C10 - LIPID MODIFYING AGENTS PLAIN

2010
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
CARDIOVASCULAR SYSTEM
LIPID MODIFYING AGENTS PLAIN
LIPID MODIFYING AGENTS PLAIN
P 9242K Tablet 10mg 30 30.00 MG 15,066 376,631
P 9243L Tablet 20mg 30 30.00 MG 44,377 1,469,966
P 9244M Tablet 40mg 30 30.00 MG 62,263 2,762,581
P 9245N Tablet 80mg 30 30.00 MG 23,101 1,370,274
FIBRATES
C10AB05 FENOFIBRATE
P 9022W Tablet 48mg 60 0.20 GM 42,000 1,258,323
P 9023X Tablet 145mg 30 0.20 GM 555,856 23,170,458
P 9246P Tablet 48mg 60 0.20 GM 2,166 64,990
P 9247Q Tablet 145mg 30 0.20 GM 18,847 786,589
C10AB04 GEMFIBROZIL
P 1453L Tablet 600mg 1.20 GM 186,770 5,547,647
P 9248R Tablet 600mg 60 1.20 GM 4,164 123,688
BILE ACID SEQUESTRANTS
C10AC02 COLESTIPOL HYDROCHLORIDE
P 1224K Sachets 5g 120 20.00 GM 1,005 76,133
C10AC01 COLESTYRAMINE
P 2967E Sachets 4.7g (equiv to 4g cholestyramine) 14.00 GM 33,347 2,107,303
P 9249T Sachets 4.7g (equiv to 4g cholestyramine) 50, 2 14.00 GM 1,923 122,991
NICOTINIC ACID AND DERIVATIVES
C10AD02 NICOTINIC ACID
A 19191 Tablet 250mg 2.00 GM 3,589 —
OTHER LIPID MODIFYING AGENTS
C10AX09 EZETIMIBE
P 8757X Tablet 10mg 30 10.00 MG 992,309 70,580,724
LIPID MODIFYING AGENTS COMBINATIONS
HMG COA REDUCTASE INHIBITORS IN COMBINATION WITH OTHER LIPID MOD AGENTS
C10BA02 SIMVASTATIN and EZETIMIBE
P 8881K Tablet 40mg-10mg 30 — — 351,582 37,893,027
P 8882L Tablet 80mg-10mg 30 — — 322,609 39,972,235
P 9483D Tablet 10mg-10mg 30 — — 10,537 935,164
P 9484E Tablet 10mg-20mg 30 — — 14,156 1,365,656
HMG COA REDUCTASE INHIBITORS, OTHER COMBINATIONS
C10BX03 ATORVASTATIN and AMLODIPINE
P 9049G Tablet 10mg (base) 5mg (base) 30 — — 81,212 4,187,140
P 9050H Tablet 20mg (base) 5mg (base) 30 — — 184,749 12,517,604
P 9051J Tablet 40mg (base) 5mg (base) 30 — — 196,592 17,462,585
P 9052K Tablet 80mg (base) 5mg (base) 30 — — 66,680 8,000,743
P 9053L Tablet 10mg (base) 10mg (base) 30 — — 58,068 3,398,053
P 9054M Tablet 20mg (base) 10mg (base) 30 — — 160,468 12,066,603
P 9055N Tablet 40mg (base) 10mg (base) 30 — — 210,049 20,215,075
P 9056P Tablet 80mg (base) 10mg (base) 30 — — 85,130 10,842,524
Last updated
1 January 2010